Stay updated on Dupilumab in Pediatric Peanut Allergy Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Pediatric Peanut Allergy Clinical Trial page.

Latest updates to the Dupilumab in Pediatric Peanut Allergy Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedPublications section wording updated to indicate that publications are automatically filled from PubMed and may not be about the study. The revision/version label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check26 days agoChange DetectedDeleted the funding-lapse notice from the page. This change does not affect study data, eligibility criteria, or results.SummaryDifference0.4%

- Check40 days agoChange DetectedCore study information (title, objectives, eligibility criteria, interventions, outcomes, and locations) remains unchanged between the screenshots, with only minor formatting adjustments observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check69 days agoChange DetectedAdditions introduce a government operating-status notice and a version update to v3.2.0; deletions remove the previous v3.1.0 tag. The main impact is informing users about current status and a version change, with no changes to core offers or pricing.SummaryDifference3%

- Check76 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page revision was updated from v3.0.1 to v3.0.2, indicating a minor patch. The 'Back to Top' element was removed.SummaryDifference0.2%

Stay in the know with updates to Dupilumab in Pediatric Peanut Allergy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Pediatric Peanut Allergy Clinical Trial page.